Credit Suisse’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Credit Suisse’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-209,537	Closed	-$8.83M	–	3191
2023 Q2	$8.83M	Buy	209,537 +113,031	+117%	+$4.57M	0.01%	982
2023 Q1	$3.44M	Buy	96,506 +4,589	+5%	+$167K	﹤0.01%	1550
2022 Q4	$3.37M	Buy	91,917 +442	+0.5%	+$17.5K	﹤0.01%	1565
2022 Q3	$4.31M	Sell	91,475 -483	-0.5%	-$31.2K	﹤0.01%	1341
2022 Q2	$6.59M	Sell	91,958 -5,574	-6%	-$408K	0.01%	1131
2022 Q1	$7.89M	Buy	97,532 +2,317	+2%	+$196K	0.01%	1157
2021 Q4	$9.78M	Sell	95,215 -1,889	-2%	-$181K	0.01%	1515
2021 Q3	$8.49M	Buy	97,104 +3,632	+4%	+$329K	﹤0.01%	1653
2021 Q2	$8.37M	Buy	93,472 +21,796	+30%	+$1.84M	﹤0.01%	1687
2021 Q1	$5.44M	Buy	71,676 +57,456	+404%	+$4.33M	﹤0.01%	2008
2020 Q4	$969K	Buy	+14,220	New	+$887K	﹤0.01%	3364
2020 Q3	–	Sell	-8,617	Closed	-$502K	–	4170
2020 Q2	$502K	Buy	+8,617	New	+$463K	﹤0.01%	3329
2020 Q1	–	Sell	-63,371	Closed	-$3.77M	–	4315
2019 Q4	$3.77M	Buy	63,371 +3,247	+5%	+$175K	﹤0.01%	2082
2019 Q3	$3.2M	Sell	60,124 -626	-1%	-$32.1K	﹤0.01%	2115
2019 Q2	$3.1M	Sell	60,750 -8,513	-12%	-$396K	﹤0.01%	2127
2019 Q1	$3.58M	Buy	69,263 +11,774	+20%	+$571K	﹤0.01%	1968
2018 Q4	$2.26M	Buy	57,489 +2,425	+4%	+$113K	﹤0.01%	2141
2018 Q3	$2.84M	Sell	55,064 -10,916	-17%	-$534K	﹤0.01%	2093
2018 Q2	$3.09M	Sell	65,980 -5,455	-8%	-$226K	﹤0.01%	2102
2018 Q1	$2.54M	Sell	71,435 -20,566	-22%	-$806K	﹤0.01%	2229
2017 Q4	$4.01M	Sell	92,001 -78,960	-46%	-$3.69M	﹤0.01%	1923
2017 Q3	$8.94M	Buy	170,961 +76,272	+81%	+$4.25M	0.01%	1319
2017 Q2	$5.54M	Buy	94,689 +37,358	+65%	+$1.94M	0.01%	1570
2017 Q1	$2.63M	Sell	57,331 -6,562	-10%	-$326K	﹤0.01%	2150
2016 Q4	$3.36M	Sell	63,893 -7,130	-10%	-$345K	﹤0.01%	1989
2016 Q3	$3.17M	Sell	71,023 -26,677	-27%	-$1.16M	﹤0.01%	2019
2016 Q2	$3.73M	Buy	97,700 +59,606	+156%	+$2.62M	﹤0.01%	1843
2016 Q1	$1.57M	Sell	38,094 -68,012	-64%	-$2.8M	﹤0.01%	2386
2015 Q4	$5.15M	Buy	106,106 +93,829	+764%	+$4.17M	0.01%	1557
2015 Q3	$491K	Sell	12,277 -1,126	-8%	-$49.2K	﹤0.01%	3401
2015 Q2	$538K	Sell	13,403 -1,075	-7%	-$37.1K	﹤0.01%	3668
2015 Q1	$474K	Buy	+14,478	New	+$400K	﹤0.01%	3577

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Credit Suisse's SYNH Position: Q3 2023 in Review

Credit Suisse sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 209,537 shares — an estimated $8.83M sold.

Credit Suisse first reported a position in SYNH in Q1 2015 and held it in 32 quarters. The position peaked at $9.78M in Q4 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

Credit Suisse reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Credit Suisse sold 209,537 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $8.83M.
Credit Suisse first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2015 and held it in 32 quarters.
Credit Suisse's Syneos Health, Inc. Class A Common Stock position peaked at $9.78M in Q4 2021.
10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Credit Suisse's 13F filing for Q3 2023, filed 13 Nov 2023.